Charles Schwab Investment Management Inc Humacyte, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 775,718 shares of HUMA stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
775,718
Previous 721,318
7.54%
Holding current value
$3.3 Million
Previous $3.92 Million
0.15%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HUMA
# of Institutions
158Shares Held
35.7MCall Options Held
284KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$30.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$21.6 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$20.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$8.69 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.4 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $439M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...